Signalling pathways involved in hypoxia‐induced renal fibrosis

M Liu, X Ning, R Li, Z Yang, X Yang… - Journal of Cellular …, 2017 - Wiley Online Library
Renal fibrosis is the common pathological hallmark of progressive chronic kidney disease
(CKD) with diverse aetiologies. Recent researches have highlighted the critical role of …

Determinants of kidney oxygen consumption and their relationship to tissue oxygen tension in diabetes and hypertension

P Hansell, WJ Welch, RC Blantz… - Clinical and Experimental …, 2013 - Wiley Online Library
The high renal oxygen (O2) demand is associated primarily with tubular O2 consumption
(Qo2) necessary for solute reabsorption. Increasing O2 delivery relative to demand via …

Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy

R Bessho, Y Takiyama, T Takiyama, H Kitsunai… - Scientific reports, 2019 - nature.com
Previous studies have demonstrated intrarenal hypoxia in patients with diabetes. Hypoxia-
inducible factor (HIF)-1 plays an important role in hypoxia-induced tubulointerstitial fibrosis …

Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney

S Kume, T Uzu, K Horiike… - The Journal of …, 2010 - Am Soc Clin Investig
Mitochondrial oxidative damage is a basic mechanism of aging, and multiple studies
demonstrate that this process is attenuated by calorie restriction (CR). However, the …

Dapagliflozin, SGLT2 inhibitor, attenuates renal ischemia-reperfusion injury

YK Chang, H Choi, JY Jeong, KR Na, KW Lee, BJ Lim… - PloS one, 2016 - journals.plos.org
Dapagliflozin, a new type of drug used to treat diabetes mellitus (DM), is a sodium/glucose
cotransporter 2 (SGLT2) inhibitor. Although some studies showed that SGLT2 inhibition …

Targeting hypoxia-inducible factors for the treatment of anemia in chronic kidney disease patients

F Locatelli, S Fishbane, GA Block… - American journal of …, 2017 - karger.com
Background: Anemia, a common complication of chronic kidney disease (CKD), has
previously been attributed primarily to decreased production of erythropoietin. More recently …

Sirt1–hypoxia‐inducible factor‐1α interaction is a key mediator of tubulointerstitial damage in the aged kidney

DR Ryu, MR Yu, KH Kong, H Kim, SH Kwon… - Aging …, 2019 - Wiley Online Library
Although it is known that the expression and activity of sirtuin 1 (Sirt1) decrease in the aged
kidney, the role of interaction between Sirt1 and hypoxia‐inducible factor (HIF)‐1α is largely …

SIRT1 attenuates renal fibrosis by repressing HIF-2α

P Li, Y Liu, X Qin, K Chen, R Wang, L Yuan… - Cell Death …, 2021 - nature.com
Abstract Sirtuin 1 (SIRT1) is a nicotinamide adenine dinucleotide (NAD+)-dependent
deacetylase belonging to class III histone deacetylases. Previous studies have shown that …

Capillary rarefaction, hypoxia, VEGF and angiogenesis in chronic renal disease

G Mayer - Nephrology Dialysis Transplantation, 2011 - academic.oup.com
Tubulointerstitial hypoxia and peritubular capillary rarefaction are typical features of chronic
progressive renal disease. In response to low oxygen supply, hypoxia-inducible factors …

[HTML][HTML] High glucose activates HIF-1-mediated signal transduction in glomerular mesangial cells through a carbohydrate response element binding protein

T Isoe, Y Makino, K Mizumoto, H Sakagami, Y Fujita… - Kidney international, 2010 - Elsevier
High glucose evokes a variety of signals in mesangial cells that alter cellular functions
responsible for the development of diabetic glomerulopathy. The hypoxia-inducible factor-1α …